Capricor Therapeutics (CAPR) Goodwill & Intangibles (2013 - 2021)
Capricor Therapeutics (CAPR) recorded quarterly Goodwill & Intangibles of $1083.0 in Q1 2021, down 49.98% quarter-over-quarter from $2165.0 in Q4 2020, and down 79.99% on a YoY basis from $5413.0 in Q1 2020.
Capricor Therapeutics (CAPR) Goodwill & Intangibles (2013 - 2021) Analysis & Trends
Capricor Therapeutics' Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $1083.0 for Q1 2021.
- In Q1 2021, Goodwill & Intangibles fell 79.99% year-over-year to $1083.0; the TTM figure through Mar 2021 stood at $1083.0 (down 79.99% YoY), while the FY2020 annual figure was $2165.0, down 66.67% from the prior year.
- Goodwill & Intangibles was $1083.0 for Q1 2021 at Capricor Therapeutics, down from $2165.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $130066.0 in Q1 2017 to a low of $1083.0 in Q1 2021.
- Historically, Goodwill & Intangibles has averaged $48107.1 across 5 years, with a median of $38952.0 in 2019.
- Biggest YoY gain for Goodwill & Intangibles was 34.59% in 2017; the steepest drop was 92.95% in 2017.
- A 5-year view of Goodwill & Intangibles shows it stood at $93048.0 in 2017, then tumbled by 46.51% to $49772.0 in 2018, then sank by 86.95% to $6495.0 in 2019, then tumbled by 66.67% to $2165.0 in 2020, then slumped by 49.98% to $1083.0 in 2021.
- The last three Goodwill & Intangibles figures came in at $1083.0 (Q1 2021), $2165.0 (Q4 2020), and $3248.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1,083.00 |
| Dec 31, 2020 | 2,165.00 |
| Sep 30, 2020 | 3,248.00 |
| Jun 30, 2020 | 4,330.00 |
| Mar 31, 2020 | 5,413.00 |
| Dec 31, 2019 | 6,495.00 |
| Sep 30, 2019 | 17,314.00 |
| Jun 30, 2019 | 28,133.00 |
| Mar 31, 2019 | 38,952.00 |
| Dec 31, 2018 | 49,772.00 |
| Sep 30, 2018 | 60,591.00 |
| Jun 30, 2018 | 71,410.00 |
| Mar 31, 2018 | 82,229.00 |
| Dec 31, 2017 | 93,048.00 |
| Sep 30, 2017 | 105,692.00 |
| Jun 30, 2017 | 117,879.00 |
| Mar 31, 2017 | 130,066.00 |
| Dec 31, 2016 | 142,253.00 |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |